Sep 11, 2022US FDA approved BMS Sotyktu (deucravacitinib) for moderate to severe plaque psoriasis |iPharmaCenter
May 30, 2022FDA approved two Opdivo based regimens as a 1L treatment for ESCC | FDA News | iPharmaCenter
May 29, 2022FDA approved Kymriah for follicular lymphoma | Novartis | News | Cancer | | Updates | iPharmaCenter
Dec 23, 2021FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK